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A patient with classical symptoms of non-ketotic hyperglycinaemia (NKH) is presented. Threonine 
dehydratase was undetectable in a liver autopsy specimen, which was obtained within t h of death and 
immediately frozen at -70  °C. Activities of four marker enzymes were normal. This represents the first 
documentation of an inborn error of threonine metabolism and a new explanation of NKH. 
Recently we made an observation i a patient with NKH 
(McKusick 23830) which suggested that a disorder of 
threonine metabolism is the cause of this disease. Since 
the manifestations of NKH have been attributed to high 
glycine concentrations in the central nervous system, 
(CNS), and since threonine is a precursor of glycine in 
CNS (Maher and Wurtman, 1980), we treated two 
infants with a threonine-free formula for 1 week (Krieger 
and Nigro, 1983). In order to provide minimum th- 
reonine requirements homogenized milk was added, but 
not until the seventh day. One of the two patients 
deteriorated suddenly on the seventh day, with clinical 
manifestations similar to those observed uring the first 
week of life. Surprisingly, CFS glycine had not increased, 
but there was a 16 and 19 fold elevation of threonine in 
CSF and plasma, respectively. We hypothesized that the 
unbalanced iet caused excessive protein catabolism 
and that the endogenous threonine load was not meta- 
bolized because of an enzymatic block. A disorder of 
threonine metabolism was also suggested by the finding 
of slightly elevated threonine and serine concentrations 
in plasma nd CSF on four of nine tests, performed prior 
to the dietary treatment. 
Of the three known enzymes with activity toward 
threonine, one was previously measured in NKH and 
found to be normal (Tada et al., 1969, 1974). It is serine 
transhydroxymethylase (STHM) (EC 2.1.2.1), which is 
active toward serine and threonine, also called threonine 
aldolase (EC 4.1.2.5) (Schirch and Gross, 1968). The 
other two enzymes are threonine dehydrogenase (EC 
t.l.l.d) and threonine dehydratase (TD) (EC 4.2.1.16). 
We hypothesized (Figure l) that deficiency of either one 
of these two enzymes could increase the metabolic load 
on STHM and that the resultant competition between 
threonine and serine for STHM might inhibit serine 
formation from glycine, causing hyperglycinaemia. The 
observed eficiency in glycine cleavage, which is rarely 
complete, thus could be a secondary phenomenon. 
The original patient was no longer available for study. 
We therefore measured TD activity in the autopsy 
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specimen of another patient, who is briefly presented. 
TD was measured because it appears to be the enzyme 
most responsive to increased metabolic threonine loads 
(White et al., 1978) and its deficiency would thus have a 
more profound effect than deficiency of the 
dehydrogenase. 
MATERIALS AND METHODS 
The liver specimen was obtained within 1 h of death and 
stored at -70  °C for 4 months until the assays were 
performed. Three control specimens were stored for 1-7 
days and obtained within 2-4 h of death. Two biopsy 
specimens were stored for 6 years. The control patients 
were four cases with congenital heart disease and one 
with lymphoangiomatous di ease, ages 6 months to 4 
years. The assay of TD was performed according to the 
method of Nishimura and Greenberg (1961), as 
modified by Yeung and Yeung (1972). The reaction 
product was measured by a method described by 
Goldstein et al. (1962). The following marker enzymes 
were measured: ornithine transcarbamylase (Prescott 
and Jones, 1969), (kindly performed by Dr Lynn 
Fleischer, Detroit), convertase (Mehler et al., 1958), 
lactate dehydrogenase (Schwartz and Bodansky, 1960), 
and glutamate dehydrogenase (Fahien and Cohen, 
1970), (kindly performed by Dr R. A. Mitchell, Detroit). 
CASE DESCRIPTION 
The patient had an uneventful delivery and early neo- 
natal course, but paucity of movements and lack of 
interest in food gradually became apparent. At 6 months 
of age, he was investigated at the Winnipeg Children's 
Hospital because of failure to suck, progressive hy- 
potonia and lethargy, causing inadequate ventilation, 
for which he required ventilatory assistance. Myoclonic 
jerks and seizure activity, consisting of increased exten- 
sor tone, were observed. An electroencephalogram sho- 
wed burst suppression. There was no history of vomit- 
ing. Routine laboratory investigations were negative; 
notably, there was no evidence of ketoacidosis, either by 
history or laboratory tests. However, a urine organic 
acid screen was not done. Amino acid analysis by 
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Figure 1 Non-ketotic hyperglycinaemia; proposed block and enzyme inhibition. The observed deficiency of threonine dehydratase 
(solid bar) or a deficiency ofthreonine dehydrogenase (open bar)could explain the partial deficiency of glycine cleavage (double 
dashed line), which as been reported in the literature, because threonine competes with glycine for serine transhydroxymethylase 
(dotted line). This hypothesis i  compatible with observation in a previously reported case with NKH (K¢lvraa et al., 1980), where 
labelled glycine was administered and the label (asterisk) was observed in d-glycerate, with trace amounts inserine and cystathionine 
column chromatography revealed elevation of plasma 
and cerebrospinal fluid glycine concentrations, 1920 and 
370 pmol/l, respectively (normal 220 and 6.6 gmol/1). A 
diagnosis of NKH was made and he was placed on 
sodium benzoate and Clonazepam; strychnine was gi- 
ven in varying doses ranging from 0.5 to 
1.5 mg kg- 1 day- 1, depending on clinical condition. 
Within 1 week some improvement was noted, evidenced 
by increased muscle tone and spontaneous movements. 
Stopping treatment at 9 months of age was followed by 
increased seizure activity and failure to suck. Treatment 
was reinstituted, but lethargy increased 1 month later 
despite therapy. There was little spontaneous movement 
and the patient did not focus or follow. He was then 
placed on valium, folic acid, choline and sodium ben- 
zoate. One month later, at age 11 months, therapy was 
gradually discontinued, except for gavage feeding. His 
condition remained essentially unchanged. He withdrew 
to painful stimuli, but was otherwise unresponsive, with 
intermittent seizures consisting of flinging of the arms, 
eye rolling and stiffening. Sudden cardiorespiratory 
arrest occurred at 12½ months of age following a lumbar 
puncture which had not presented technical difficulties. 
Autopsy revealed petechial haemorrhages of the thyroid 
and pleura, and diffuse spongy changes of cerebral white 
matter. 
RESULTS 
Activity of TD was not detectable in the liver specimen of 
the patient; control activity was 52-107 pmol h-  1 g- 1 
tissue in the three autopsy specimens and 
42-156 gmol h-  1 g- 1 in the biopsy specimen. Lactate 
dehydrogenase was 57 ~o and glutamate dehydrogenase 
83 ~ of controls. Convertase activity was normal. 
Ornithine transcarbamylase was 3974 txmol h-  1 g- ~ ti- 
ssue (normal: 3346 _+ 782). The effect of handling was 
measured in rat liver. In two specimens, tored for 6 
months at -70°C,  TD activity was 112 and 
113pmolh-ag -1 tissue, compared to 105 and 
115 pmol h-  1 g- 1 in two fresh specimens. Following 
storage at -70°C  for 6 years, activity was only 
42 gmol h - 1 g- 1. When a fresh specimen was exposed to 
room temperature for 2 and 4 h, activity decreased from 
105 to 96 and 87 pmol h-  1 g- ~, respectively. When the 
specimen that had been stored for 6 years at - 70 °C was 
thawed and then exposed for 2 h at room temperature, 
activity decreased from 42 to 30 ~tmol h-  I g- 1. 
DISCUSSION 
A disorder of threonine metabolism has not been suspec- 
ted before in NKH and only one poorly documented 
case of hyperthreoninaemia has ever been reported 
(Reddi, t978). Since it is unlikely that mutations pare 
consistently one amino acid, we suggest that the rarity of 
hyperthreoninaemia is attributable tothe availability of 
more than one metabolic pathway. Only an excessive 
metabolic load will, under these circumstances, reveal 
evidence of a metabolic defect. Whether the deficiency of 
threonine dehydratase, observed by us, is indeed the 
primary cause of NKH must now be proven on fresh 
liver biopsies, although the studies in rat liver indicate 
that our observation is not an artifact. Moreover, the 
finding of normal activity of ornithine trans- 
carbamylase-known to be an unstable nzyme-also 
supports our belief that the patient's pecimen was 
viable. 
Variable deficiency of glycine cleavage is the only 
biochemical abnormality that has been recognized in 
NKH to date. Similar degrees of deficiency occur in 
ketotic hyperglycinaemias, including methylmalonic 
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and propionic acidaemia (T da et al., 1974; Ando et al., 
1972). These hyperglycinaemias are clinically and bio- 
chemically different han NKH. Deficiency of glycine 
cleavage has also been described in a patient with d- 
glyceric acidaemia (K¢lvraa et al., 1980) who had the 
clinical manifestations of NKH. Subsequently another 
patient with a typical clinical picture of NKH was 
described who also excreted large amounts of glyceric 
acid (Grandgeorge et al., 1980). It is not certain whether 
deficiency of d-glycerate dehydrogenase or glycine clea- 
vage was the primary defect in these cases. 
Perry et al. (1977) demonstrated complete deficiency 
of glycine cleavage in frozen brain tissue of five patients 
dying with NKH. Only one patient with ketotic hyper- 
glycinaemia was analysed and found to be normal, while 
a case with an unidentified form of hyperglycinaemia 
had partial deficiency. In view of the small number of 
cases and the use of autopsy specimens, it remains 
questionable whether involvement of brain by the en- 
zyme defect indeed distinguishes NKH from the ketotic 
hyperglycinaemias. Partial deficiency ofglycine cleavage 
in liver of cases with ketotic hyperglycinaemia is re- 
cognized as a secondary phenomenon. Deficiency of 
glycine cleavage thus cannot be used in the diagnosis of 
NKH. Elevation of CSF glycine and absence of keto- 
acidosis is currently the only distinctive feature of NKH. 
Prenatal diagnosis may be attempted by demonstrating 
glycine elevation in amniotic fluid (Garcia-Castro et al., 
1982), but the reliability of this approach remains to be 
proven. Demonstration of a specific enzyme defect in 
NKH thus may provide a more reliable method for 
prenatal diagnosis, if it can be shown that the enzyme is 
present in amniotic fibroblasts. 
It is possible that the described eficiency" of TD is 
secondary to inhibition by glycine or by an unknown 
intermediary metabolite. However, the reverse is a more 
likely explanation since the TD defect was complete, 
whereas ubstantial glycine cleavage activity remained 
in most of the reported cases. The reverse xplanation is 
compatible with current concepts of intermediary th- 
reonine metabolism. Since the affinity of STHM is 
greatest for serine and lowest for threonine, competition 
between glycine and threonine can be anticipated when 
there is a block ofthreonine catabolism due to deficiency 
of either, threonine dehydratase or threonine dehy- 
drogenase (Figure 1). This explanation is also supported 
by the occasional finding of slightly elevated levels of 
plasma serine and threonine in our original patient. 
Using labelled glycine, K¢Ivraa et al. (1980) showed 
that, aside from d-glyceric acid, trace amounts of the 
label appear in serine and cystathionine. This obser- 
vation is compatible with our hypothesis. Appearance of 
the label in cystathionine explains the elevation of ~- 
aminobutyric acid, which was observed at the time of 
hyperthreoninaemia in the original case, although itwas 
not included in the report (Krieger and Nigro, 1983). 
This metabolite is derived from ~-ketobutyric a id. Since 
~-ketobutyrate d rives from both, serine as well as 
threonine, it is possible that threonine dehydrogenase 
was defective in this original case. 
Our hypothesis also explains the finding of d-glycerate 
in the patient of KNvraa et al. (1976) who showed 
clinical manifestations of NKH but had, in addition, 
glycerate dehydrogenase activity in the heterozygous 
range. This amount of enzyme function should not cause 
accumulation ofd-glycerate unless there is an excessive 
load of serine, which is not readily converted to glycine. 
We hypothesize that this occurs in NKH because of the 
competition between serine, threonine and glycine for 
STHM. Mutations appear to be common in man, most 
of which are silent because of heterozygosity of recessive 
traits or because compensatory pathways exist. One 
may therefore anticipate that heterozygous mutations 
can co-exist with other inborn errors of metabolism. 
Partial deficiency of glycerate dehydrogenase, as obser- 
ved by K~lvraa et al. (1976), would be biochemically 
'silent' unless the load is excessive. Co-existence of this 
defect hus may have been a chance occurrence. 
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Case Report 
P INK NAPK INS - PRESENTING FEATURE IN A 
CASE OF ALKAPTONURIA 
D. A. Suthertand 1,A. D. NicoP '2 and A. J. Williams I 
Pink staining of an infant's napkin is commonly 
attributed to uric acid crystals in urine whilst other, rarer 
causes include haemoglobinuria, dyes from sweets, 
anthocyanins from beetroot or berries, drugs, porphyria 
and contamination with Serratia marcescens (Cone, 
1968). We report a case of alkaptonuria (McKusick 
20350) presenting with pink staining of the napkin. 
E.E. is a healthy, well-developed boy, the result of a 
normal pregnancy; his sister is 3 years older and is well. 
E.E. was referred at age 8 weeks after his mother 
reported pink-stained napkins to the Health Visitor. 
Discolorations had been noticed from age 1 week 
(washing both napkins and baby's buttocks produced a 
deep brown colour). Vitamin supplement adminis- 
tration coincided with disappearance of staining, which 
returned on discontinuing vitamins. Maternal vitamin C 
administration yielded unstained napkins but these 
became pink again when breast-feeding ceased. 
Additional vitamin C in E.E.'s diet keeps his napkins 
discoloration-free. 
Urine samples were generally clear, of normal pH, and 
did not exhibit suspicious darkening. They were positive 
for reducing substances, negative for glucose, giving a 
transient blue-green colour with ferric chloride. 
Following alkalinization, urine darkened rapidly from 
the meniscus downwards, becoming very dark brown 
within hours. Alkaptonuria was confirmed as follows. 
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Spectroscopic examination of urine diluted in 
0.2 tool/1 phosphate buffer pH 6.5 revealed the presence 
of large quantities of a substance with an absorption 
maximum at 290.2nm: the absorption maximum for 
homogentisic acid is 290nm at pH6.8. Under similar 
conditions uric acid has a maximum at 291nm. 
d2A 
However, derivative spectra, namely, ~-  (Fell, 1981), 
from dilutions of E.E.'s urine were quite different from 
those of control urines. Furthermore, the maximum at 
290.2 nm rapidly disappeared on treating E.E.'s urine 
with horse-radish peroxidase and glutathione (La Du 
and Zannoni, 1963), whereas uricase effected little 
change. By contrast, control urines with absorption 
maxima around 293nm behaved in the converse 
manner. Finally, gas-liquid chromatography of E.E.'s 
urinary organic acids yielded avery large peak which co- 
chromatographed with authentic homogentisic acid 
(Dr, D. Isherwood, Alder Hey Hospital, Liverpool). 
Aqueous homogentisic acid at pH 6 turns pink in 
daylight. In 1929 Garrod observed red-coloured urine in 
alkaptonuric subjects. Thus it is to be expected that 
alkaptonuria may reveal itself by pink staining of 
napkins and not exclusively by the traditional brown 
discoloration. 
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